ClinicalTrials.gg
CompletedNCT06163703Updated Jun 1, 2026

Strengthening Child Social-Emotional and Lifestyle Health in Families Experiencing Stress

An interventional study of Family Life Skills Triple P in Child Behavior, Sedentary Behavior and Self-regulation, sponsored by University of South Carolina. Completed at 1 site in United States. Open to participants aged 3 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by University of South Carolina · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
3 Years to 9 Years
Sex
All
01

Study summary

This study evaluates feasibility and preliminary efficacy of a parent-based prevention program to promote social-emotional and lifestyle behavior health among 3- to 9-year-old children in families experiencing major stressors.

Read the detailed description

Social-emotional difficulties and unhealthy lifestyle behaviors are prevalent among children in the U.S. and are associated with negative health outcomes. These challenges are even more pronounced among families who deal with major stressors, such as parental trauma history and mental health difficulties, parental chronic illness (e.g., HIV), parental substance use, economic disadvantage, and racial discrimination. The purpose of this study is to assess the feasibility, acceptability, and preliminary efficacy of a parent-based preventive intervention targeting parental self-regulation, stress reduction, and positive parenting, to promote child social-emotional and lifestyle behavior health, among families where the parents (a) have a child aged 3 to 9 years old, (b) have concerns about their child's behavior, mood, and/or lifestyle health, and (c) are experiencing major stressors. The intervention to be tested is based on Family Life Skills Triple P.

02

Conditions studied

  • Child Behavior
  • Sedentary Behavior
  • Self-regulation
  • Parenting
03

In context

Child Behavior

224 studies on the registry are indexed under Child Behavior; 41 are open to participants now.

This study's enrollment of 86 is below the median of 140 across 197 interventional studies indexed under Child Behavior.

Browse Child Behavior studies →

Lead sponsor

University of South Carolina is the lead sponsor of 197 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Child between the ages of 3-9 years
  2. Parent/caregiver willing to engage in the intervention who

    • is at least 18 years of age
    • is primary caregiver or guardian for the participating child
    • has concerns about the child's mood, behavior, and/or lifestyle health
    • is experiencing two or more major stressors of the following: trauma history, mental health difficulties, living with , racial discrimination, substance misuse, and/or financial strain
    • is English speaking.

Exclusion criteria

Exclusion Criteria:

a. Parent or child has

  • a significant cognitive disability, developmental delay, or pervasive developmental disorder
  • active suicidal or homicidal ideation
  • psychotic symptoms (active hallucinations, delusions, or impaired thought processes)
  • ongoing family violence occurring within the home and/or active involvement of child protect services related to child maltreatment allegations.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Intervention

    Participants in the intervention arm will receive a 12-session parent-based prevention program based on Family Life Skills Triple P.

    Behavioral: Family Life Skills Triple P

  • No intervention
    Waitlist Control

    Participants in the waitlist control arm will not receive any intervention during the clinical trial. They will be placed on a waitlist and then offered the intervention once post assessments are complete.

Interventions

  • BehavioralFamily Life Skills Triple P

    The intervention is a 12-session program that combines parenting support with trauma-informed life skills coaching. It includes content related to positive parenting strategies, self-regulation, coping with emotions, effective communication, dealing with the past, and developing healthy habits.

06

What researchers measure

Primary outcomes

  1. Intervention acceptability

    Assessed as parent-reported liking and approval of the intervention on a 5-point response scale and satisfaction with the intervention on a 4-point response scale, with higher scores indicating greater acceptability.

    Time frame: post-intervention (T2, Weeks 16-18)

  2. Intervention appropriateness

    Assessed as parent-reported applicability and suitability of the intervention on a 5-point response scale, with higher scores indicating greater appropriateness.

    Time frame: post-intervention (T2, Weeks 16-18)

  3. Intervention feasibility--Implementability

    Assessed as parent-reported ease of use and overall implementability of the intervention on a 5-point response scale, with higher scores indicating greater feasibility.

    Time frame: post-intervention (T2, Weeks 16-18)

  4. Intervention feasibility--Attendance

    Assessed as parent attendance at intervention sessions using weekly attendance logs

    Time frame: Weekly throughout intervention period (Weeks 1-17)

  5. Trial-related feasibility--Recruitment capability

    Assessed as the proportion of eligible children who enroll in the study.

    Time frame: Continuously throughout recruitment period, up to 156 weeks

  6. Trial-related feasibility--Retention

    Assessed as the proportion of enrolled children who remain in the study through the length of the intervention, with proportion who dropout and reasons for dropout also collected.

    Time frame: Continuously through study period (Weeks 1-30)

  7. Child social-emotional difficulties: Problem behaviors

    Assessed as parent-reported frequency of child problematic behaviors on a 7-point response scale (higher scores indicate greater frequency).

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  8. Child social-emotional difficulties: Depression and anxiety symptoms

    Assessed as parent-reported frequency of child depression and anxiety symptoms on a 4-point response scale (higher scores indicate greater frequency).

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  9. Child social-emotional difficulties: Strengths and difficulties

    Assessed as parent-reported agreement with statements about child strengths and difficulties on a 3-point response scale (higher scores indicate greater endorsement).

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  10. Child physical activity

    Assessed as daily time spent sedentary and in various activity intensities using a wrist-worn accelerometer.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  11. Child screen time

    Assessed as parent-reported average daily time spent engaging in screen time, including: watching TV; using a computer; gaming on a console or hand-held device; and using a tablet or smart phone for activities such as viewing videos, playing games, and browsing the internet.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  12. Child sleep

    Assessed using a wrist-worn accelerometer to calculate nighttime sleep duration and using a validated measure of parent-reported child sleep-wake behaviors on a 6-point response scale, with lower scores indicating more problematic behaviors.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

Secondary outcomes

  1. Parenting practices

    Assessed as parent self-reported frequency of positive and negative parenting behaviors on a 5-point response scale, with higher subscale scores indicating greater frequency of the respective behaviors.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  2. Parenting self-regulation

    Assessed as parent self-rated agreement with statements about self-regulation as a parent on a 7-point response scale, with higher scores indicating greater self-regulation.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

  3. Parenting stress

    Assessed as parent self-rated frequency and intensity of daily parenting hassles on a 4--point response scale, with higher scores indicating more frequent and intense hassles.

    Time frame: baseline (T1, Weeks 0-2); post-intervention (T2, Weeks 16-18); follow-up (T3, Week 30)

07

Study locations

1 site
  • University of South Carolina
    Columbia, South Carolina 29208, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Apr 2026, 26 months.

Of 140 non-industry interventional studies with no phase under Child Behavior, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 26 months is above that.

Counting every sponsor, half of 141 studies reached it within 20 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2023
First posted
Dec 11, 2023
StartActual
Feb 9, 2024
Primary completionActual
Apr 30, 2026
CompletionActual
May 7, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06163703
Responsible party
Nada Goodrum (Assistant Professor, University of South Carolina) — Principal investigator
First posted
Dec 11, 2023
Start date
Feb 9, 2024
Primary completion
Apr 30, 2026
Completion
May 7, 2026
Last update
Jun 1, 2026

Study contacts

Nada M Goodrum, Ph.D.
principal investigator · University of South Carolina

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion